Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.06%180.960.4%$209.53m
AMRNAmarin Corporation Plc Sponsored ADR
-0.13%15.362.0%$193.87m
PRGOPerrigo Co. Plc
-3.01%63.426.8%$106.48m
JAZZJazz Pharmaceuticals Plc
-5.36%142.612.2%$102.70m
ENDPEndo International Plc
-4.81%12.878.9%$66.11m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-3.16%128.006.3%$63.30m
MNKMallinckrodt Plc
-0.82%30.8221.1%$55.30m
SAGESAGE Therapeutics, Inc.
-3.56%105.159.6%$50.91m
ICPTIntercept Pharmaceuticals, Inc.
-6.05%94.6118.7%$46.35m
HZNPHorizon Pharma plc
-1.79%21.467.4%$45.64m
UTHRUnited Therapeutics Corporation
-2.02%110.4414.4%$42.81m
CTLTCatalent Inc
-0.93%37.872.4%$36.16m
PTLAPortola Pharmaceuticals, Inc.
-4.18%19.247.7%$34.39m
ICLRICON Plc
-1.34%136.144.1%$34.09m
AERIAerie Pharmaceuticals, Inc.
-4.32%41.456.9%$27.41m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.